DHS Bulletins and News
- MAB 99-18-06: Update to Submission of Claims that Require the National Provider Identifier (NPI) of a Medical Assistance Enrolled Ordering, Referring or Prescribing Provider (PDF)
- MAB 99-11-05: Provider Screening of Employees and Contractors for Exclusion from Participation in Federal Health Care Programs and the Effect of Exclusion on Participation (PDF)
- MAB 99-25-01: Limited English Proficiency Requirements (PDF)
- MAB 99-23-08: Updates to Guidelines for the Delivery of Physical Health Services via Telehealth (PDF)
- Electronic Visit Verification Indicator (Quick Tips #264) (PDF)
- MAB 26-24-01: Ambulance Services: Important Billing update (PDF)
- MAB 01-23-26: Street medicine (PDF)
- MAB 01-21-59: SARS-CoV-2 Monoclonal antibody product updates (PDF)
- MAB 08-22-19: Naloxone distribution by federally qualified health centers and rural health clinics (PDF)
- MAB 01-22-42: Adult Vaccine Procedure Code updates and additions (PDF)
- MAB 01-22-41: Additions to the Medical Assistance fee schedule for monkeypox laboratory testing and vaccines (PDF)
- MAB 01-21-04: SARS-CoV-2 Vaccine Administration for Beneficiaries Who Are Homebound (PDF)
- MAB 01-21-11: Expansion of Providers for the Administration of SARS-CoV-2 Vaccines and Monoclonal Antibody Therapy (PDF)
- MAB 99-21-03: Reinstatement of Prior Authorization Requirements for Certain Services (PDF)
- MAB Provider Preventable Conditions Policy (PDF)
- MAB 01-21-03: Fee increase for the administration of SARS-CoV-2 vaccines (PDF)
- MAB 01-21-01: Janssen Biotech Inc. SARS-CoV-2 vaccine added to MA fee schedule (PDF)
- MAB 01-20-62 — SARS-CoV-2 Vaccine Updates (PDF)
- MAB 01-19-65 (PDF)
- MAB 99-99-06 (PDF)
- MAB 99-17-02 (PDF)